[ad_1]
Pfizer seeks vaccine approval in Europe … “Vaccination available this month”
[앵커]Pfizer, a US pharmaceutical company, and Bioentech, Germany, have applied for approval to sell the Corona 19 vaccine in Europe.
Vaccination should be available as early as this month.
In the midst of all this, the crown crisis in Italy is nearing the worst.
This is Park Hye-jun PD.
[리포터]US pharmaceutical company Pfizer and Germany’s Bio Entech have applied for approval to sell the Corona 19 vaccine in Europe.
It is the second time since Modena that it has requested the approval of the vaccine by the European Medicines Agency.
According to Pfizer and Bio-Entech, the vaccine, jointly developed by the two companies, has a 95% immune effect.
The European Medicines Agency says it will decide whether to approve the vaccine for emergency by 29 at the latest.
If the approval process goes as planned, the vaccine will likely be available later this month.
“With the urgent need for vaccinations, the Commission will do its best to make decisions as quickly as possible.”
Interestingly, the vaccine could receive the 19 crown proliferation tax in Europe.
Especially in Italy, the situation in Europe is so serious that there is even the word “a terrible and tragic November”.
There have been 800,000 new cases in Italy in the past month, more than the total number of confirmed cases in the past eight months from February to October.
The number of infected people worldwide last month was around 17.15 million, and the monthly tally showed the highest number since the outbreak.
Of these, the United States accounted for about 4.5 million people, a quarter.
In November, the number of deaths worldwide was 270,000, with 6.3 deaths per minute.
There are also concerns that the damage will increase as the Northern Hemisphere enters the winter season when viral activity is active.
This is Hyejun Park on Yonhap News TV
Yonhap News TV article inquiries and reports: katok / line jebo23
(End)
Source link
